XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
ASSETS    
Operating (including $1,666,691 and $1,226,918 of consolidated variable interest entities, respectively) $ 6,758,728 $ 6,125,957
Construction-in-progress 769,882 599,260
Asset held for sale 0 33,856
Real estate, at cost, total 7,528,610 6,759,073
Less accumulated depreciation and amortization (including $236,391 and $209,239 of consolidated variable interest entities, respectively) (1,828,845) (1,729,234)
Net real estate 5,699,765 5,029,839
Cash and cash equivalents 22,850 23,368
Accounts and notes receivable, net 200,878 116,749
Mortgage notes receivable, net 30,429 29,904
Investment in real estate partnerships 23,925 14,864
Prepaid expenses and other assets 243,290 208,555
TOTAL ASSETS 6,221,137 5,423,279
Liabilities    
Mortgages payable (including $461,873 and $439,120 of consolidated variable interest entities, respectively) 493,240 471,117
Capital lease obligations 71,565 71,590
Notes payable 320,718 279,151
Senior notes and debentures 2,377,939 1,976,594
Accounts payable and accrued expenses 206,441 201,756
Dividends payable 73,466 71,440
Security deposits payable 16,698 16,285
Other liabilities and deferred credits 175,464 115,817
Total liabilities 3,735,531 3,203,750
Commitments and contingencies (Note 6)
Redeemable noncontrolling interests 151,815 143,694
Shareholders’ equity    
Common shares of beneficial interest, $.01 par, 100,000,000 shares authorized, 72,542,909 and 71,995,897 shares issued and outstanding, respectively 728 722
Additional paid-in capital 2,773,890 2,718,325
Accumulated dividends in excess of net income (724,919) (749,734)
Accumulated other comprehensive loss (742) (2,577)
Total shareholders’ equity of the Trust 2,208,954 1,976,733
Noncontrolling interests 124,837 99,102
Total shareholders’ equity 2,333,791 2,075,835
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 6,221,137 5,423,279
5.0% Series C Cumulative Redeemable Preferred    
Shareholders’ equity    
Preferred shares, authorized 15,000,000 shares, $.01 par 150,000 0
5.417% Series 1 Cumulative Convertible Preferred    
Shareholders’ equity    
Preferred shares, authorized 15,000,000 shares, $.01 par $ 9,997 $ 9,997